Christensen Bret 4

What Happened
Bret Christensen, CEO of biote Corp. (BTMD), was granted a derivative award covering 441,653 shares on April 1, 2026. The Form 4 reports an acquisition at $0.00 per share (no cash paid at grant). This is a grant/award (not a sale), meaning Christensen received potential future equity subject to vesting rather than immediate shares sold or a cash transaction.

Key Details

• Transaction date: April 1, 2026; Form 4 filed April 3, 2026 (covers the April 1 grant).
• Transaction type: A = Grant / Award (derivative securities). Reported price: $0.00 per share.
• Shares granted: 441,653 derivative shares (option/award). Total dollar amount at grant not reported on the Form 4.
• Shares owned after transaction: Not disclosed in this filing.
• Vesting note (from filing): 25% of the shares vest on April 1, 2027; remaining shares vest in 36 substantially equal monthly installments thereafter, subject to continuous service.
• Filing timeliness: Reported on Form 4 two days after the grant date (filing appears timely).

Context
This is a time‑based equity award (the footnote refers to an “option” vesting schedule). Such grants give the executive a potential stake over time if they remain with the company and any vesting conditions are met; they do not represent immediate sale proceeds or a change in free‑float until exercised/vested and any shares issued. The filing is informational and does not state any immediate market action (no shares sold).